Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test
Post Content
Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test
San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) — Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in anticipation of a Series B financing in 2025. Proceeds will support the continued commercialization of Mindera’s lead product, Mind.Px™. “This capital raise will fuel
Podimetrics, Inc. Ranks No. 500 on the 2024 Inc. 5000
Podimetrics earns a spot at No. 500 on the Inc. 5000 list for 2024, highlighting the success of its innovative approach to helping prevent diabetes-related amputations through advanced home-based monitoring and trusted patient education.
Podimetrics, Inc. Ranks No. 500 on the 2024 Inc. 5000 Read More »
Protected: SHD Fund III
There is no excerpt because this is a protected post.
Protected: SHD Fund III Read More »
Protected: SHD Fund I
There is no excerpt because this is a protected post.
Protected: SHD Fund I Read More »
Protected: SHD Fund II
There is no excerpt because this is a protected post.
Protected: SHD Fund II Read More »
Koya Medical Raises $26 Million in Series B Funding
Koya Medical secures $26M Series B led by 3×5 Partners to drive innovation in lymphatic and venous care and advance active compression treatments for patients.
Koya Medical Raises $26 Million in Series B Funding Read More »